Is Anti-Müllerian Hormone Associated with IVF Outcomes in Young Patients with Diminished Ovarian Reserve? | Zendy

Nigel Pereira | Zendy; Robert Setton | Zendy; Allison C. Petrini | Zendy; Jovana P. Lekovich | Zendy; Rony T. Elias | Zendy; Steven D. Spandorfer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is Anti-Müllerian Hormone Associated with IVF Outcomes in Young Patients with Diminished Ovarian Reserve?

Author(s) -

Nigel Pereira,

Robert Setton,

Allison C. Petrini,

Jovana P. Lekovich,

Rony T. Elias,

Steven D. Spandorfer

Publication year - 2016

Publication title -

women s health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.363

H-Index - 39

eISSN - 1745-5065

pISSN - 1745-5057

DOI - 10.2217/whe.15.102

Subject(s) - anti müllerian hormone , ovarian reserve , medicine , gynecology , hormone , reproductive endocrinology and infertility , obstetrics , infertility , pregnancy , endocrinology , biology , genetics

Aim: To investigate whether anti-Müllerian hormone (AMH) is associated with IVF cycle outcomes in young patients with diminished ovarian reserve.Materials & methods: Retrospective study of patients 1 ng/ml and 0.5 ng/ml.Results: In total, 1005 patients were included. Patients in the >1 ng/ml group required lesser gonadotropins compared with the <1 ng/ml and the <0.5 ng/ml group. More oocytes were retrieved from the same group compared with the latter two (p < 0.001). Despite these differences, the overall rates of clinical pregnancy, spontaneous abortion and live birth were comparable between the two groups.Conclusion: In patients with diminished ovarian reserve who have good quality embryos, AMH is not associated with clinical pregnancy, spontaneous miscarriage or live birth rates.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research